Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil

BG acknowledges funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). PML acknowledges funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding...

Descripción completa

Detalles Bibliográficos
Autores: Cardoso, Sandra Wagner, Luz, Paula Mendes, Velasque, Luciane, Torres, Thiago, Coelho, Lara, Freedberg, Kenneth A., Veloso, Valdiléa G., Walensky, Rochelle P., Grinsztejn, Beatriz
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2014
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Repositório Institucional da FIOCRUZ (ARCA)
Idioma:inglés
OAI Identifier:oai:arca.fiocruz.br:icict/11189
Acceso en línea:https://arca.fiocruz.br/handle/icict/11189
Access Level:acceso abierto
Palabra clave:HIV
Antiretroviral Therapy, Highly Active
Effectiveness
Brazil/ethnology
Terapia Antirretroviral de Alta Atividade
Efetividade
Brasil/etnologia
Descripción
Sumario:BG acknowledges funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). PML acknowledges funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). KAF and RPW acknowledge funding from National Institute of Allergy and Infectious Diseases (NIAID, R01 AI058736, R01 AI093269).

Similares en LA Referencia